Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia

Read More

Hemostemix Featured at Innovations in Wound Healing 2025, Key West, December 11-14

Read More

Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000

Read More

Hemostemix Grants Stock Options

Read More

Hemostemix Welcomes Shaune Harding, OStJ, RN as Director of Patient Care & Clinical Operations

Read More

Hemostemix to Attend DFU 2025 San Antonio and Closed its Private Placement

Read More

Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring Two

Read More

Investor Relations

Hemostemix Closes CDN $280,594 Private Placement

Read More

Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds

Read More

Hemostemix Closes Private Placement of $461,230

Read More